(Q44546852)

4 December 2017

1 reference

title

Chemoradiation in pancreatic carcinoma (English)

1 reference

4 December 2017

0 references

L Claude

1

1 reference

4 December 2017

F Mornex

series ordinal

2

1 reference

4 December 2017

language of work or name

French

0 references

publication date

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

7

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

254-265

1 reference

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study11Data management by Italian Trials in Medical Oncology (I.T.M.O.) Scientific Service

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Fight against cancer of the exocrine pancreas: stagnation or progress? The point of view of the Fondation française de cancérologie digestive (FFCD)

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

CPT-11 in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Cancer of the pancreas. 50 years of surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Combined modality therapy for stage II and stage III pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Combined chemoradiotherapy for unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Preoperative irradiation in carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Chemo-radiotherapy for localized pancreatic cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

1 reference

7 January 2021

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Adjuvant therapy of resected adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2803%2900027-1

7 January 2021

10.1016/S1278-3218(03)00027-1

Identifiers

DOI

1 reference

4 December 2017

1 reference